{"name": "Celator Pharmaceuticals",
 "permalink": "celator-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/celator-pharmaceuticals",
 "homepage_url": "http://www.celatorpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@celatorpharma.com",
 "phone_number": "(609) 243-0123",
 "description": "",
 "created_at": "Thu Sep 02 14:13:55 UTC 2010",
 "updated_at": "Tue May 07 03:41:27 UTC 2013",
 "overview": "\u003Cp\u003ECelator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0010/0352/100352v1-max-150x150.png"],
     [[242,
       72],
      "assets/images/resized/0010/0352/100352v1-max-250x250.png"],
     [[242,
       72],
      "assets/images/resized/0010/0352/100352v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Scott",
      "last_name": "Jackson",
      "permalink": "scott-jackson",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Nicole",
      "last_name": "Vitullo",
      "permalink": "nicole-vitullo",
      "image":
       {"available_sizes":
         [[[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-150x150.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-250x250.jpg"],
          [[90,
            100],
           "assets/images/resized/0026/4491/264491v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Senior Director, Business Development",
    "person":
     {"first_name": "Eric",
      "last_name": "Heil",
      "permalink": "eric-heil",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5376/265376v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$59.3M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.celatorpharma.com/new/pr_20100901.html",
    "source_description": "CELATOR\u00c2\u00ae PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING",
    "raised_amount": 20000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Thomas, McNerney \u0026 Partners",
         "permalink": "thomas-mcnerney-partners",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0008/1733/81733v1-max-150x150.png"],
             [[250,
               30],
              "assets/images/resized/0008/1733/81733v1-max-250x250.png"],
             [[450,
               54],
              "assets/images/resized/0008/1733/81733v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ventures West",
         "permalink": "ventures-west",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0001/0785/10785v1-max-150x150.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-250x250.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TL Ventures",
         "permalink": "tl-ventures",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0003/0750/30750v1-max-150x150.png"],
             [[208,
               63],
              "assets/images/resized/0003/0750/30750v1-max-250x250.png"],
             [[208,
               63],
              "assets/images/resized/0003/0750/30750v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GrowthWorks Capital",
         "permalink": "growthworks",
         "image":
          {"available_sizes":
            [[[150,
               38],
              "assets/images/resized/0002/8728/28728v1-max-150x150.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-250x250.png"],
             [[187,
               48],
              "assets/images/resized/0002/8728/28728v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BDC Venture Capital",
         "permalink": "bdc-venture-capital-2",
         "image":
          {"available_sizes":
            [[[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-150x150.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-250x250.png"],
             [[115,
               57],
              "assets/images/resized/0001/1190/11190v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://www.celatorpharma.com/new/pr_20130430.html",
    "source_description": "CELATOR\u00ae PHARMACEUTICALS RAISES $32.5 MILLION COMPLETING A $39.3 MILLION PRIVATE PLACEMENT FINANCING",
    "raised_amount": 39300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ROTH Capital Partners",
         "permalink": "roth-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0012/5145/125145v1-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0012/5145/125145v1-max-250x250.jpg"],
             [[335,
               93],
              "assets/images/resized/0012/5145/125145v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Valence Life Sciences",
         "permalink": "valence-life-sciences",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": " 303B College Road East ",
    "address2": "",
    "zip_code": "08540",
    "city": "Princeton",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}